We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
CETRORELIX RBX (Sun Pharma ANZ Pty Ltd)
Product name
CETRORELIX RBX
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
137 (255 working days)
Active ingredients
cetrorelix
Registration type
New generic medicine
Indication
Prevention of premature luteinisation and ovulation in patients undergoing a controlled ovarian stimulation followed by oocyte pick up and assisted reproductive techniques.
In clinical trials cetrorelix was used with human menopausal gonadotrophin (HMG), however limited experience with recombinant FSH suggested similar efficacy.